Haranaka M, Young Song J, Huang KC, de Solom R, et al. A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults?>/=?60 years of age in Japan, South Korea, and Taiwan. Vaccine 2024 Jan 23:S0264-410X(24)00008-2. doi: 10.1016/j.vaccine.2024.
PMID: 38267330